Camelid single-domain antibody directed against phosphorylated tau proteins and methods for producing conjugates thereof
US11124563B2 · kind B2 · utility
1Cited by
0References
20Claims
0Family size
Assignees
Inventors
Key dates
| Filing date | Dec 2, 2019 |
| Grant date | Sep 21, 2021 |
| Priority date | — |
| Expiry date | Dec 4, 2039 |
Classification
- Technology area (CPC G)Physics
- CPC primaryG01N2800/2821
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The present invention relates to variable domains of a camelid heavy-chain antibodies directed against a phosphorylated tau protein and conjugates thereof. The present invention also relates to the use of these domains or conjugates for treating or diagnosing disorders mediated by neurofibrillary tangles, neuropil threads or dystrophic neurites, such as tauopathies.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.